Atlas FDA

Dimension Enzymatic Creatinine Flex reagent cartridge, DF270. The ECRE method is an in vitro diagnostic test for the qua

FDA device recall Z-0485-2009 · posted 2008-12-13 · Terminated

Recall details

Recalling firm
Dade Behring, Inc.
Reason for recall
Reagent may exhibit unflagged inaccurate patient sample results.
Action taken
The recalling firm telephoned all customers on 9/29/08 to inform them of the problem. Customers were issued a letter dated 9/29/08 (and a response form) with instructions. Customers were instructed to complete the response form and fax (302-631-7242) it to Siemens Healthcare Diagnostics. For questions or additional information, contact the Siemens Technical Solutions Center at 800-441-9250.
Root cause
Component design/selection
Status
Terminated
Product code
JFY
Quantity affected
12,773 cartons
Distribution
Nationwide Distribution.
Date initiated
2008-09-29
Date posted
2008-12-13
Date terminated
2009-03-27
Location
Newark, DE

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
DIMENSION ENZYMATIC CREATININE FLEX REAGENT CARTRIDGE WITH MODEL DF270 (K073055)Dade Behring, Inc.2008-01-03